Hyun-Soo Kim
Chief Executive Officer at PHARMICELL CO., LTD.
Net worth: 28 M $ as of 30/05/2024
Profile
Hyun-Soo Kim is currently the Chief Executive Officer and Director at Pharmicell Co., Ltd.
He previously worked as Co-CEO, Director, Head-Research & Development at FCB Twelve Co., Ltd.
from 2009 to 2011, and as Chief Executive Officer & Director at FCB-Pharmicell Co., Ltd.
from 2010 to 2011.
He completed his undergraduate degree at Yonsei University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
PHARMICELL CO., LTD
10.89% | 28/02/2024 | 6,535,247 ( 10.89% ) | 28 M $ | 30/05/2024 |
Hyun-Soo Kim active positions
Companies | Position | Start |
---|---|---|
PHARMICELL CO., LTD. | Chief Executive Officer | 18/08/2009 |
Former positions of Hyun-Soo Kim
Companies | Position | End |
---|---|---|
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables FCB Twelve Co., Ltd. is engaged in manufacturing, distributing, and selling cell therapeutic drugs and apparels. It operates in two segments: Biotechnology and Fashion. The Biotechnology Segment offers stem cell therapeutic drugs, adult stem cell banking service, and stem cell skin care solution. The Fashion Segment offers garments and other fashion accessories under three brands such as basic by GV2, studio yume, and le body lingerie. It also provides hospital management consulting, resort amenities and services, as well as technology transfer. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea. | President | 05/10/2011 |
FCB-Pharmicell Co., Ltd.
FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services FCB-Pharmicell Co., Ltd. develops adult cell stem therapy. It also provides testing services for cell drugs. It has an operating centre in Europe. The company was founded by Kim Hyoo-soo and is headquartered in Seongnam, Korea. | President | 26/06/2011 |
Training of Hyun-Soo Kim
Yonsei University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PHARMICELL CO., LTD. | Health Technology |
Private companies | 2 |
---|---|
FCB-Pharmicell Co., Ltd.
FCB-Pharmicell Co., Ltd. Miscellaneous Commercial ServicesCommercial Services FCB-Pharmicell Co., Ltd. develops adult cell stem therapy. It also provides testing services for cell drugs. It has an operating centre in Europe. The company was founded by Kim Hyoo-soo and is headquartered in Seongnam, Korea. | Commercial Services |
FCB Twelve Co., Ltd.
FCB Twelve Co., Ltd. Apparel/FootwearConsumer Non-Durables FCB Twelve Co., Ltd. is engaged in manufacturing, distributing, and selling cell therapeutic drugs and apparels. It operates in two segments: Biotechnology and Fashion. The Biotechnology Segment offers stem cell therapeutic drugs, adult stem cell banking service, and stem cell skin care solution. The Fashion Segment offers garments and other fashion accessories under three brands such as basic by GV2, studio yume, and le body lingerie. It also provides hospital management consulting, resort amenities and services, as well as technology transfer. The company was founded on August 20, 1968 and is headquartered in Seoul, South Korea. | Consumer Non-Durables |
- Stock Market
- Insiders
- Hyun-Soo Kim